跳至主要内容
临床试验/NCT06143358
NCT06143358已完成不适用

Treatment of Acute Exacerbation of Chronic Obstructive Pulmonary Disease With Qingkepingchuan Granules Clinical Observation of Phlegm-Heat and Lung Depletion

Zhang Zhijie1 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2022年1月1日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
100
试验地点
1
主要终点
Chinese Medicine Symptoms Scale

研究概览

简要总结

Through the clinical observation of Qingcheng Pingxian Granules in the treatment of acute exacerbation of chronic obstructive pulmonary disease (phlegm-heat lung syndrome), (1) to evaluate the safety of Qingcheng Pingxian Granules in the acute exacerbation of chronic obstructive pulmonary disease; (2) to observe the clinical efficacy of Qingcheng Pingxian Granules in the treatment of acute exacerbation of chronic obstructive pulmonary disease, to provide an effective medication and solution for the treatment of acute exacerbation of chronic obstructive pulmonary disease, and to provide data for the development of the further application of Qingcheng Pingxian Granules.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
40 Years 至 90 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Meet the diagnostic criteria of AECOPD.
  • Chinese medicine diagnosis is consistent with phlegm-heat and lung depletion evidence
  • 40 years old ≤ age ≤ 90 years old
  • Patients who signed the informed consent form and volunteered to participate in the study

排除标准

  • Combined with other primary lung diseases such as bronchial asthma, bronchiectasis, etc.
  • Combination of serious cardiovascular, urinary, digestive, haematopoietic, endocrine metabolic system diseases, other psychiatric and neurological diseases.
  • Pregnant or lactating patients.
  • Allergic to the clinical trial drugs.

研究组 & 干预措施

treatment group

Experimental

Qingkepingchuan Granules+Conventional basic therapy

干预措施: Qingkepingchuan Granules (Drug)

control subjects

Other

Conventional basic therapy

干预措施: conventional treatment (Other)

结局指标

主要结局

Chinese Medicine Symptoms Scale

时间窗: Before the start of treatment, 1 week of treatment, 2 weeks of treatment, 1 month of follow-up

Record changes in patients' TCM indicators。The scale includes cough, wheezing, shortness of breath, sputum volume, chest tightness, sputum colour, sputum quality, fever, thirst, irritability, constipation, tongue coating, and pulse. The first four items are rated 0-6, and the last nine items are rated 0-3, with higher ratings indicating poorer treatment outcomes.

COPD assessment test

时间窗: Before the start of treatment, 1 week of treatment, 2 weeks of treatment, 1 month of follow-up

Record changes in the patient's condition

breathlessness measurement using the modified British Medical Research Council

时间窗: Before the start of treatment, 1 week of treatment, 2 weeks of treatment, 1 month of follow-up

Record changes in the patient's condition

次要结局

  • 6-minute walking test(Before the start of treatment, 2 weeks of treatment)

研究者

发起方
Zhang Zhijie
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Zhang Zhijie

PhD

Beijing University of Chinese Medicine

研究点 (1)

Loading locations...

相似试验